September is Thyroid Cancer Awareness Month. With numerous occasions on our collective health calendar radars, this is one that tends to be...
Cancer
This blog features the latest resources and information from experts in Sunnybrook’s Odette Cancer Program.
Advances in Lung Cancer Treatment: Changing the Lung Cancer Story
Lung cancer remains the leading contributor for cancer-related deaths for men and women, yet it is often overlooked—due to stigma and attribution...
Bev Moir is ‘crushing it’ for cancer research
Bev Moir counts herself as lucky. Diagnosed with stage four lung cancer in 2019, she underwent biomarker testing at Sunnybrook – an advanced...
Using the combined powers of AI and philanthropy to improve cancer treatment planning
Sunnybrook’s trailblazing efforts in the field of artificial intelligence (AI) and digital pathology began by looking into the past. Odette Cancer...
How Sunnybrook is providing care for colorectal patients 50 and younger
March is Colorectal Cancer Awareness Month. Historically, 90 per cent of colorectal cancer diagnoses have been in patients older than 50 years of...
Colon cancer at 41: Bryna’s story
At 41, Bryna Dilman was working full-time, married, parenting her daughter and finding ways to stay active eight months into a global pandemic. She...
Supporting patients through their cancer journey: Meet social worker Torey Belzberg
A person facing a cancer diagnosis has so much more to them than that diagnosis. That’s how Torey Belzberg approaches the people she meets in her...
Sunnybrook acquires new scanner that will expand imaging capacity and innovation
Earlier this year, the Sunnybrook medical imaging team acquired a state-of-the-art positron emission tomography/computed tomography (PET/CT) scanner...
Behind the Research: Breaking through the blood-brain barrier with focused ultrasound
Dr. Nir Lipsman explains how focused ultrasound has the potential to change the treatment care path for patients with brain cancer and other...
Behind the Research: A medical oncologist on tough-to-reach tumours and promising research
"It feels amazing to be a part of something that’s a world-first and that shows so much potential. It’s a good first step in being able to offer...